COVOVAX & CORBEVAX approved for emergency use | Covid India Update

Amid the ongoing resurgence of new Covid-19 cases in the country, an expert panel of the Central Drugs Standard Control Organisation has approved two new vaccines and one anti-viral drug for restricted use in emergency situation.

The CDSCO has granted the Emergency Use Authorization (EUA) to COVOVAX, developed by the Serum Institute of India; CORBEVAX, developed by the Hyderabad-based firm Biological-E; and the anti-viral drug Molnupiravir.